The quest for sustained commercial growth creates numerous challenges in an ever-evolving business world. Conventional beliefs in fixed market boundaries, a tendency to avoid risks, and a lack of a systematic approach to innovation often constrain the pursuit of more profitable breakthrough solutions. However, there’s hope: the Blue Ocean methodology. This course, deeply integrated with insights from Innovation360, is designed to equip participants with robust strategies, allowing them to redefine their market and harness the vast potential of uncharted market spaces. But it’s not only about knowledge but rather transformation. Participants will master the art of integrating the Blue Ocean Strategy with the Innovation360 framework, ensuring maximum organizational readiness for innovation. Through empirical insights, hands-on tools, and interactive sessions, this curriculum offers a roadmap for companies to achieve groundbreaking differentiation and confidently redefine their industry’s horizons.
Absorb the core principles of the Blue Ocean Strategy and Innovation 360.
Familiarize with tools and templates from both frameworks, ensuring systematic exploration of fresh market opportunities.
Design strategies that encompass radical innovations for long-term growth and competitive advantage.
Challenge traditional market boundaries and innovatively reshape industry norms.
PRICE
USD29
CERTIFICATE
At the conclusion of the course, you have the option of purchasing a blockchained digital micro-credential certificate for USD29.
AUDIENCE
The course is designed for executives who manage the innovation and strategic planning process in their organization. Basic business acumen is required for this course.
YOUR INSTRUCTOR
Kasia Hein-Peters, MD
Kasia leverages human ingenuity to address the world’s most pressing health challenges. She collaborates with life science and digital health companies to amplify innovations.
Kasia graduated as a medical doctor and completed her residency in psychiatry at the Medical University in Wroclaw, Poland. After working as a clinical physician, she transitioned to the pharmaceutical industry, overseeing the launches of several first-in-class treatments that significantly raised the standards of patient care. She held positions at Eli Lilly, Merck (MSD), Novartis, Sanofi, and Terumo BCT. Later, she focused on med-tech and digital tech startups as an advisor, mentor, and fractional executive. With extensive experience in developing enterprise, portfolio, and brand strategies, Kasia creates market conditions conducive to growth through policy, advocacy, and scientific initiatives. Recently, she achieved board certification from the American Board of AI in Medicine and became a licensed innovation practitioner through INNOVATION360.
Kasia aids healthcare, digital health, and life science firms in reaching their strategic aspirations, securing sustainable growth, launching leading brands, and scaling their organizations by enhancing innovation capabilities. She bolsters the chances of bringing health innovations to the market, benefiting both patient outcomes and the performance of healthcare organizations.
